<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>slow-growing mycobacteria on Mycobacterial Infection Research Unit</title>
    <link>https://miru-ffm.org/tags/slow-growing-mycobacteria/</link>
    <description>Recent content in slow-growing mycobacteria on Mycobacterial Infection Research Unit</description>
    <generator>Source Themes academia (https://sourcethemes.com/academic/)</generator>
    <language>en-us</language>
    <copyright>Copyright &amp;copy; {year}</copyright>
    <lastBuildDate>Thu, 27 Jun 2024 00:00:00 +0000</lastBuildDate>
    
	    <atom:link href="https://miru-ffm.org/tags/slow-growing-mycobacteria/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>New publication in the Journal of Infection</title>
      <link>https://miru-ffm.org/news/post4/</link>
      <pubDate>Thu, 27 Jun 2024 00:00:00 +0000</pubDate>
      
      <guid>https://miru-ffm.org/news/post4/</guid>
      <description>&lt;img src=&#34;gr1.jpg&#34;&gt;
&lt;br&gt;
&lt;i&gt;Mycobacterium malmoense&lt;/i&gt; is a rare cause of NTM pulmonary disease. In this systemativ review and meta-analysis, we summarize the available clinical data of &lt;i&gt;M. malmoense&lt;/i&gt; infection from more than 800 patients. The pathogen is shown to be of high clinical relevance and macrolide or rifamycin containing regimens might improve survival in affected patients.  
&lt;br&gt;&lt;br&gt;
We are very happy to see the result of this Danish-German collaboration finally published in the Journal of Infection.
&lt;br&gt;&lt;br&gt;
You can find the paper here, at 
&lt;a href=&#34;https://miru-ffm.org/publication/yjinf_2024&#34;&gt;miru-ffm.org&lt;/a&gt;, &lt;a href=&#34;https://www.journalofinfection.com/article/S0163-4453(24)00137-3/fulltext&#34;&gt; the journal&#39;s homepage&lt;/a&gt;, or at &lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/38906266/&#34;&gt;PubMed&lt;/a&gt;.
</description>
    </item>
    
    <item>
      <title>Clinical spectrum and relevance of Mycobacterium malmoense: Systematic review and meta-analysis of 859 patients</title>
      <link>https://miru-ffm.org/publication/yjinf_2024/</link>
      <pubDate>Wed, 19 Jun 2024 00:00:00 +0000</pubDate>
      
      <guid>https://miru-ffm.org/publication/yjinf_2024/</guid>
      <description>&lt;p&gt;&lt;a href=&#34;https://www.journalofinfection.com/article/S0163-4453(24)00137-3/fulltext&#34;&gt;At Journal Homepage&lt;/a&gt;
&lt;br&gt;
&lt;br&gt;
&lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/38906266/&#34;&gt;At PubMed&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Differential radiological features of patients infected or colonised with slow-growing non-tuberculous mycobacteria</title>
      <link>https://miru-ffm.org/publication/scirep_2024/</link>
      <pubDate>Mon, 10 Jun 2024 00:00:00 +0000</pubDate>
      
      <guid>https://miru-ffm.org/publication/scirep_2024/</guid>
      <description>&lt;p&gt;&lt;a href=&#34;https://www.nature.com/articles/s41598-024-64029-0&#34;&gt;At Journal Homepage&lt;/a&gt;
&lt;br&gt;
&lt;br&gt;
&lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/38858499/&#34;&gt;At PubMed&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>New publication in Scientific Reports</title>
      <link>https://miru-ffm.org/news/post3/</link>
      <pubDate>Mon, 10 Jun 2024 00:00:00 +0000</pubDate>
      
      <guid>https://miru-ffm.org/news/post3/</guid>
      <description>&lt;img src=&#34;figure_2.png&#34;&gt;
&lt;br&gt;
In collaboration with the Department of Radiology at University Hospital Frankfurt, we investigated the radiological features of patients infected or colonised with slow-growing non-tuberculous mycobacteria. We applied a score, originally described for MAC pulmonary disease, to other SGM-species. We are very happy that the manuscript has been accepted for publication in &lt;i&gt;Scientific Reports&lt;/i&gt;, now.
&lt;br&gt;
&lt;br&gt;
You can find the paper here, at 
&lt;a href=&#34;https://miru-ffm.org/publication/scirep_2024&#34;&gt;miru-ffm.org&lt;/a&gt;, &lt;a href=&#34;https://www.nature.com/articles/s41598-024-64029-0&#34;&gt; the journal&#39;s homepage&lt;/a&gt;, or at &lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/38858499/&#34;&gt;PubMed&lt;/a&gt;.
</description>
    </item>
    
    <item>
      <title>NTM-registry</title>
      <link>https://miru-ffm.org/project/registry/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      
      <guid>https://miru-ffm.org/project/registry/</guid>
      <description>&lt;p&gt;&lt;strong&gt;Introduction&lt;/strong&gt;: In contrast to tuberculosis, infections due to non-tuberculous mycobacteria (NTM) are not notifiable. However, there is accumulating evidence that their incidence is increasing in countries with low endemicity of tuberculosis. In addition, the pathogenicity of different NTM varies widely.
&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;Objectives&lt;/strong&gt;: Investigation of the epidemiological and clinical features of patients infected or colonised with non-tuberculous mycobacteria (NTM).
&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;Methods&lt;/strong&gt;: The ntmscope_registry will establish needed data collecting tools in a monocentric approach, after an initial test phase the registry will become available to additional centers with the aim of becoming the first NTM-registry in Germany. This is to be achieved with the Institute for Medical Informatics (IMI) of the Goethe University Frankfurt.
&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;Status&lt;/strong&gt;: &lt;em&gt;Registry currently being constructed&lt;/em&gt;&lt;br&gt;
&lt;br&gt;
&lt;br&gt;
&lt;a href=&#34;https://www.osse-register.de/&#34;&gt;www.osse-register.de&lt;/a&gt;
&lt;br&gt;
&lt;br&gt;
&lt;a href=&#34;https://miru-ffm.org/contact/&#34;&gt;More information&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>NTMscope-Eco</title>
      <link>https://miru-ffm.org/project/eco/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      
      <guid>https://miru-ffm.org/project/eco/</guid>
      <description>&lt;p&gt;&lt;strong&gt;Introduction&lt;/strong&gt;: Non-tuberculous mycobacteria (NTM) are recovered from a variety of environmental samples. In other countries, potable water, for example from shower heads, has been a frequent source. Patients with NTM-pulmonary disease have been shown to acquire their bacterial isolates from their household water samples in some cases. However, in Germany, NTM have not been isolated from water samples until now and only been found in soil, dust, and others.&lt;/p&gt;
&lt;p&gt;&lt;br&gt;
&lt;strong&gt;Objectives&lt;/strong&gt;: Isolation of NTM from water samples.
&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;Methods&lt;/strong&gt;: Environmental sampling, culture, molecular identification techniques.&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;Status&lt;/strong&gt;: &lt;em&gt;Currently running&lt;/em&gt;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;
&lt;a href=&#34;https://eu.jotform.com/222856429317058&#34;&gt;Include sample&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;
&lt;a href=&#34;https://miru-ffm.org/contact/&#34;&gt;More information&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>NTMscope-MAC</title>
      <link>https://miru-ffm.org/project/ntmscope/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      
      <guid>https://miru-ffm.org/project/ntmscope/</guid>
      <description>&lt;p&gt;&lt;strong&gt;Introduction&lt;/strong&gt;: &lt;em&gt;M. avium&lt;/em&gt; complex is the predominant slow-growing mycobacterium in Europe and North America and consists – among others – of the species &lt;em&gt;M. avium, M. intracellulare&lt;/em&gt; and &lt;em&gt;M. chimaera&lt;/em&gt;. The latter has been involved in a global outbreak of infections in patients that underwent cardiosurgical interventions. Here, contaminated heater-cooler machines could be identified as point infection source. All three species are present in the environment and have been isolated from water sources in patients homes. However, human-to-human transmission has not been established so far. In CF-patients, &lt;em&gt;M. avium&lt;/em&gt; complex is the NTM second most frequently isolated in Europe. If there are dominant circulating clones, as has been described in &lt;em&gt;M. abscessus&lt;/em&gt;, remains unclear until now.&lt;/p&gt;
&lt;p&gt;&lt;br&gt;
&lt;strong&gt;Objectives&lt;/strong&gt;: Investigation of the genomic epidemiology of &lt;em&gt;M. avium&lt;/em&gt; complex in multiple centers in Europe.
&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;Methods&lt;/strong&gt;: Clinical and epidemiological data-analysis, whole genome sequencing, genotypic drug susceptibility testing.&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;Status&lt;/strong&gt;: &lt;em&gt;Currently analysing&lt;/em&gt;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;
&lt;a href=&#34;https://miru-ffm.org/contact/&#34;&gt;More information&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>NTMscope-Meta</title>
      <link>https://miru-ffm.org/project/meta/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      
      <guid>https://miru-ffm.org/project/meta/</guid>
      <description>&lt;p&gt;&lt;strong&gt;Introduction&lt;/strong&gt;: Treatment and management of rare NTM remains a considerable challenge as randomized controlled trials or systematic studies are scarce. Most therapeutic recommendations are based on &lt;em&gt;in vitro&lt;/em&gt; data or clinical experience with more frequent NTM. The optimal therapy for most infections remains unclear.
&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;Objectives&lt;/strong&gt;: Investigation of clinical data regarding the clinical manifestations and therapeutic outcomes of rare NTM.
&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;Methods&lt;/strong&gt;: Literature review, (individual patient data) meta analysis.
&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;Status&lt;/strong&gt;: &lt;em&gt;Ongoing&lt;/em&gt;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;
&lt;a href=&#34;https://miru-ffm.org/contact/&#34;&gt;More information&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
